Calcineurin inhibitor nephrotoxicity: Reduction in dose results in marked improvement in renal function in patients with coexisting chronic allograft nephropathy

Clinical Transplantation

Volumn 16, Issue 3, 2002, Pages 191-195

  Pilmore, Helen L ^a   Dittmer, Ian D ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

Calcineurin inhibitor; Chronic allograft nephropathy; Creatinine; Hyalinization; Nephrotoxicity

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CREATININE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ARTICLE; CHRONICITY; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIAGNOSTIC PROCEDURE; DOSE KIDNEY FUNCTION RELATION; DRUG BLOOD LEVEL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INCIDENCE; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; NEPHROTOXICITY; PRIORITY JOURNAL;

CALCINEURIN; CHRONIC DISEASE; CREATININE; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; TRANSPLANTATION, HOMOLOGOUS;

EID: 0036303411     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.2002.01119.x     Document Type: Article

References (16)

1. Insights into chronic cyclosporine nephrotoxicity
2. The side effects of cyclosporine-A and tacrolimus
3. Mechanisms of nephrotoxicity
4. Renal biopsy morphology in renal transplantation. A comparative study of the light-microscopic appearances of biopsies from patients treated with cyclosporine A or azathioprine, prednisone and antilymphocyte globulin
5. Histopathology of calcineurin inhibitor-induced nephrotoxicity
6. The differential diagnosis between rejection and cyclosporine toxicity
7. Cyclosporine nephrotoxicity in heart and lung transplant recipients
8. International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology
9. The Banff 97 working classification of renal allograft pathology
10. Histopathological findings in well-functioning, long-term renal allografts
11. Modulation of fibroblastic cytoskeletal features during pathological situations: The role of extracellular matrix and cytokines
12. Role of transforming growth factor β1 in experimental chronic cyclosporine nephropathy
13. Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy
14. Histological chronic allograft damage index accurately predicts chronic renal allograft rejection
15. Two-hour cyclosporine level determination is the appropriate tool to monitor Neoral therapy
16. Validation of the Banff criteria for acute rejection in renal transplant biopsies